<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d520" origId="Mefloquine"><sentence id="DrugDDI.d520.s0" origId="s0" text="Drug-drug interactions with Mefloquine have not been explored in detail."><entity id="DrugDDI.d520.s0.e0" origId="s0.p1" charOffset="28-38" type="drug" text="Mefloquine"/></sentence><sentence id="DrugDDI.d520.s1" origId="s1" text="There is one report of cardiopulmonary arrest, with full recovery, in a patient who was taking a beta blocker (propranolol)."><entity id="DrugDDI.d520.s1.e0" origId="s1.p17" charOffset="97-110" type="drug" text="beta blocker"/><entity id="DrugDDI.d520.s1.e1" origId="s1.p19" charOffset="111-122" type="drug" text="propranolol"/><pair id="DrugDDI.d520.s1.p0" e1="DrugDDI.d520.s1.e0" e2="DrugDDI.d520.s1.e1" interaction="false"/></sentence><sentence id="DrugDDI.d520.s2" origId="s2" text="The effects of Mefloquineuine on the compromised cardiovascular system have not been evaluated."/><sentence id="DrugDDI.d520.s3" origId="s3" text="The benefits of Mefloquine therapy should be weighed against the possibility of adverse effects in patients with cardiac disease."><entity id="DrugDDI.d520.s3.e0" origId="s3.p29" charOffset="16-26" type="drug" text="Mefloquine"/></sentence><sentence id="DrugDDI.d520.s4" origId="s4" text="Because of the danger of a potentially fatal prolongation of the QTc interval, halofantrine must not be given simultaneously with or subsequent to Mefloquine."><entity id="DrugDDI.d520.s4.e0" origId="s4.p40" charOffset="79-91" type="drug" text="halofantrine"/><entity id="DrugDDI.d520.s4.e1" origId="s4.p48" charOffset="147-157" type="drug" text="Mefloquine"/><pair id="DrugDDI.d520.s4.p0" e1="DrugDDI.d520.s4.e0" e2="DrugDDI.d520.s4.e1" interaction="true"/></sentence><sentence id="DrugDDI.d520.s5" origId="s5" text="Concomitant administration of Mefloquine and other related compounds (eg, quinine, quinidine and chloroquine) may produce electrocardiographic abnormalities and increase the risk of convulsions."><entity id="DrugDDI.d520.s5.e0" origId="s5.p50" charOffset="30-40" type="drug" text="Mefloquine"/><entity id="DrugDDI.d520.s5.e1" origId="s5.p52" charOffset="51-68" type="drug" text="related compounds"/><entity id="DrugDDI.d520.s5.e2" origId="s5.p55" charOffset="74-81" type="drug" text="quinine"/><entity id="DrugDDI.d520.s5.e3" origId="s5.p56" charOffset="83-92" type="drug" text="quinidine"/><entity id="DrugDDI.d520.s5.e4" origId="s5.p58" charOffset="97-108" type="drug" text="chloroquine"/><pair id="DrugDDI.d520.s5.p0" e1="DrugDDI.d520.s5.e0" e2="DrugDDI.d520.s5.e1" interaction="true"/><pair id="DrugDDI.d520.s5.p1" e1="DrugDDI.d520.s5.e0" e2="DrugDDI.d520.s5.e2" interaction="true"/><pair id="DrugDDI.d520.s5.p2" e1="DrugDDI.d520.s5.e0" e2="DrugDDI.d520.s5.e3" interaction="true"/><pair id="DrugDDI.d520.s5.p3" e1="DrugDDI.d520.s5.e0" e2="DrugDDI.d520.s5.e4" interaction="true"/><pair id="DrugDDI.d520.s5.p4" e1="DrugDDI.d520.s5.e1" e2="DrugDDI.d520.s5.e2" interaction="false"/><pair id="DrugDDI.d520.s5.p5" e1="DrugDDI.d520.s5.e1" e2="DrugDDI.d520.s5.e3" interaction="false"/><pair id="DrugDDI.d520.s5.p6" e1="DrugDDI.d520.s5.e1" e2="DrugDDI.d520.s5.e4" interaction="false"/><pair id="DrugDDI.d520.s5.p7" e1="DrugDDI.d520.s5.e2" e2="DrugDDI.d520.s5.e3" interaction="false"/><pair id="DrugDDI.d520.s5.p8" e1="DrugDDI.d520.s5.e2" e2="DrugDDI.d520.s5.e4" interaction="false"/><pair id="DrugDDI.d520.s5.p9" e1="DrugDDI.d520.s5.e3" e2="DrugDDI.d520.s5.e4" interaction="false"/></sentence><sentence id="DrugDDI.d520.s6" origId="s6" text="If these drugs are to be used in the initial treatment of severe malaria, Mefloquine administration should be delayed at least 12 hours after the last dose."><entity id="DrugDDI.d520.s6.e0" origId="s6.p67" charOffset="9-14" type="drug" text="drugs"/><entity id="DrugDDI.d520.s6.e1" origId="s6.p73" charOffset="65-72" type="drug" text="malaria"/><entity id="DrugDDI.d520.s6.e2" origId="s6.p74" charOffset="74-84" type="drug" text="Mefloquine"/><pair id="DrugDDI.d520.s6.p0" e1="DrugDDI.d520.s6.e0" e2="DrugDDI.d520.s6.e1" interaction="false"/><pair id="DrugDDI.d520.s6.p1" e1="DrugDDI.d520.s6.e0" e2="DrugDDI.d520.s6.e2" interaction="true"/><pair id="DrugDDI.d520.s6.p2" e1="DrugDDI.d520.s6.e1" e2="DrugDDI.d520.s6.e2" interaction="false"/></sentence><sentence id="DrugDDI.d520.s7" origId="s7" text="There is evidence that the use of halofantrine after Mefloquineuine causes a significant lengthening of the QTc interval."><entity id="DrugDDI.d520.s7.e0" origId="s7.p84" charOffset="34-46" type="drug" text="halofantrine"/></sentence><sentence id="DrugDDI.d520.s8" origId="s8" text="Clinically significant QTc prolongation has not been found with Mefloquineuine alone."/><sentence id="DrugDDI.d520.s9" origId="s9" text="This appears to be the only clinically relevant interaction of this kind with Mefloquine, although theoretically, coadministration of other drugs known to alter cardiac conduction (eg, anti-arrhythmic or beta-adrenergic blocking agents, calcium channel blockers, antihistamines or H1-blocking agents, tricyclic antidepressants and phenothiazines) might also contribute to a prolongation of the QTc interval."><entity id="DrugDDI.d520.s9.e0" origId="s9.p101" charOffset="78-88" type="drug" text="Mefloquine"/><entity id="DrugDDI.d520.s9.e1" origId="s9.p105" charOffset="140-145" type="drug" text="drugs"/><entity id="DrugDDI.d520.s9.e2" origId="s9.p112" charOffset="185-201" type="drug" text="anti-arrhythmic"/><entity id="DrugDDI.d520.s9.e3" origId="s9.p114" charOffset="204-235" type="drug" text="beta-adrenergic blocking agents"/><entity id="DrugDDI.d520.s9.e4" origId="s9.p115" charOffset="237-261" type="drug" text="calcium channel blockers"/><entity id="DrugDDI.d520.s9.e5" origId="s9.p116" charOffset="263-277" type="drug" text="antihistamines"/><entity id="DrugDDI.d520.s9.e6" origId="s9.p119" charOffset="301-326" type="drug" text="tricyclic antidepressants"/><entity id="DrugDDI.d520.s9.e7" origId="s9.p121" charOffset="331-345" type="drug" text="phenothiazines"/><pair id="DrugDDI.d520.s9.p0" e1="DrugDDI.d520.s9.e0" e2="DrugDDI.d520.s9.e1" interaction="true"/><pair id="DrugDDI.d520.s9.p1" e1="DrugDDI.d520.s9.e0" e2="DrugDDI.d520.s9.e2" interaction="true"/><pair id="DrugDDI.d520.s9.p2" e1="DrugDDI.d520.s9.e0" e2="DrugDDI.d520.s9.e3" interaction="true"/><pair id="DrugDDI.d520.s9.p3" e1="DrugDDI.d520.s9.e0" e2="DrugDDI.d520.s9.e4" interaction="true"/><pair id="DrugDDI.d520.s9.p4" e1="DrugDDI.d520.s9.e0" e2="DrugDDI.d520.s9.e5" interaction="true"/><pair id="DrugDDI.d520.s9.p5" e1="DrugDDI.d520.s9.e0" e2="DrugDDI.d520.s9.e6" interaction="true"/><pair id="DrugDDI.d520.s9.p6" e1="DrugDDI.d520.s9.e0" e2="DrugDDI.d520.s9.e7" interaction="true"/><pair id="DrugDDI.d520.s9.p7" e1="DrugDDI.d520.s9.e1" e2="DrugDDI.d520.s9.e2" interaction="false"/><pair id="DrugDDI.d520.s9.p8" e1="DrugDDI.d520.s9.e1" e2="DrugDDI.d520.s9.e3" interaction="false"/><pair id="DrugDDI.d520.s9.p9" e1="DrugDDI.d520.s9.e1" e2="DrugDDI.d520.s9.e4" interaction="false"/><pair id="DrugDDI.d520.s9.p10" e1="DrugDDI.d520.s9.e1" e2="DrugDDI.d520.s9.e5" interaction="false"/><pair id="DrugDDI.d520.s9.p11" e1="DrugDDI.d520.s9.e1" e2="DrugDDI.d520.s9.e6" interaction="false"/><pair id="DrugDDI.d520.s9.p12" e1="DrugDDI.d520.s9.e1" e2="DrugDDI.d520.s9.e7" interaction="false"/><pair id="DrugDDI.d520.s9.p13" e1="DrugDDI.d520.s9.e2" e2="DrugDDI.d520.s9.e3" interaction="false"/><pair id="DrugDDI.d520.s9.p14" e1="DrugDDI.d520.s9.e2" e2="DrugDDI.d520.s9.e4" interaction="false"/><pair id="DrugDDI.d520.s9.p15" e1="DrugDDI.d520.s9.e2" e2="DrugDDI.d520.s9.e5" interaction="false"/><pair id="DrugDDI.d520.s9.p16" e1="DrugDDI.d520.s9.e2" e2="DrugDDI.d520.s9.e6" interaction="false"/><pair id="DrugDDI.d520.s9.p17" e1="DrugDDI.d520.s9.e2" e2="DrugDDI.d520.s9.e7" interaction="false"/><pair id="DrugDDI.d520.s9.p18" e1="DrugDDI.d520.s9.e3" e2="DrugDDI.d520.s9.e4" interaction="false"/><pair id="DrugDDI.d520.s9.p19" e1="DrugDDI.d520.s9.e3" e2="DrugDDI.d520.s9.e5" interaction="false"/><pair id="DrugDDI.d520.s9.p20" e1="DrugDDI.d520.s9.e3" e2="DrugDDI.d520.s9.e6" interaction="false"/><pair id="DrugDDI.d520.s9.p21" e1="DrugDDI.d520.s9.e3" e2="DrugDDI.d520.s9.e7" interaction="false"/><pair id="DrugDDI.d520.s9.p22" e1="DrugDDI.d520.s9.e4" e2="DrugDDI.d520.s9.e5" interaction="false"/><pair id="DrugDDI.d520.s9.p23" e1="DrugDDI.d520.s9.e4" e2="DrugDDI.d520.s9.e6" interaction="false"/><pair id="DrugDDI.d520.s9.p24" e1="DrugDDI.d520.s9.e4" e2="DrugDDI.d520.s9.e7" interaction="false"/><pair id="DrugDDI.d520.s9.p25" e1="DrugDDI.d520.s9.e5" e2="DrugDDI.d520.s9.e6" interaction="false"/><pair id="DrugDDI.d520.s9.p26" e1="DrugDDI.d520.s9.e5" e2="DrugDDI.d520.s9.e7" interaction="false"/><pair id="DrugDDI.d520.s9.p27" e1="DrugDDI.d520.s9.e6" e2="DrugDDI.d520.s9.e7" interaction="false"/></sentence><sentence id="DrugDDI.d520.s10" origId="s10" text="There are no data that conclusively establish whether the concomitant administration of Mefloquineuine and the above listed agents has an effect on cardiac function."/><sentence id="DrugDDI.d520.s11" origId="s11" text="In patients taking an anticonvulsant (eg, valproic acid, carbamazepine, phenobarbital or phenytoin), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant."><entity id="DrugDDI.d520.s11.e0" origId="s11.p142" charOffset="22-36" type="drug" text="anticonvulsant"/><entity id="DrugDDI.d520.s11.e1" origId="s11.p145" charOffset="42-55" type="drug" text="valproic acid"/><entity id="DrugDDI.d520.s11.e2" origId="s11.p146" charOffset="57-70" type="drug" text="carbamazepine"/><entity id="DrugDDI.d520.s11.e3" origId="s11.p147" charOffset="72-85" type="drug" text="phenobarbital"/><entity id="DrugDDI.d520.s11.e4" origId="s11.p149" charOffset="89-98" type="drug" text="phenytoin"/><entity id="DrugDDI.d520.s11.e5" origId="s11.p153" charOffset="124-134" type="drug" text="Mefloquine"/><entity id="DrugDDI.d520.s11.e6" origId="s11.p158" charOffset="199-213" type="drug" text="anticonvulsant"/><pair id="DrugDDI.d520.s11.p0" e1="DrugDDI.d520.s11.e0" e2="DrugDDI.d520.s11.e1" interaction="false"/><pair id="DrugDDI.d520.s11.p1" e1="DrugDDI.d520.s11.e0" e2="DrugDDI.d520.s11.e2" interaction="false"/><pair id="DrugDDI.d520.s11.p2" e1="DrugDDI.d520.s11.e0" e2="DrugDDI.d520.s11.e3" interaction="false"/><pair id="DrugDDI.d520.s11.p3" e1="DrugDDI.d520.s11.e0" e2="DrugDDI.d520.s11.e4" interaction="false"/><pair id="DrugDDI.d520.s11.p4" e1="DrugDDI.d520.s11.e0" e2="DrugDDI.d520.s11.e5" interaction="true"/><pair id="DrugDDI.d520.s11.p5" e1="DrugDDI.d520.s11.e0" e2="DrugDDI.d520.s11.e6" interaction="false"/><pair id="DrugDDI.d520.s11.p6" e1="DrugDDI.d520.s11.e1" e2="DrugDDI.d520.s11.e2" interaction="false"/><pair id="DrugDDI.d520.s11.p7" e1="DrugDDI.d520.s11.e1" e2="DrugDDI.d520.s11.e3" interaction="false"/><pair id="DrugDDI.d520.s11.p8" e1="DrugDDI.d520.s11.e1" e2="DrugDDI.d520.s11.e4" interaction="false"/><pair id="DrugDDI.d520.s11.p9" e1="DrugDDI.d520.s11.e1" e2="DrugDDI.d520.s11.e5" interaction="true"/><pair id="DrugDDI.d520.s11.p10" e1="DrugDDI.d520.s11.e1" e2="DrugDDI.d520.s11.e6" interaction="false"/><pair id="DrugDDI.d520.s11.p11" e1="DrugDDI.d520.s11.e2" e2="DrugDDI.d520.s11.e3" interaction="false"/><pair id="DrugDDI.d520.s11.p12" e1="DrugDDI.d520.s11.e2" e2="DrugDDI.d520.s11.e4" interaction="false"/><pair id="DrugDDI.d520.s11.p13" e1="DrugDDI.d520.s11.e2" e2="DrugDDI.d520.s11.e5" interaction="true"/><pair id="DrugDDI.d520.s11.p14" e1="DrugDDI.d520.s11.e2" e2="DrugDDI.d520.s11.e6" interaction="false"/><pair id="DrugDDI.d520.s11.p15" e1="DrugDDI.d520.s11.e3" e2="DrugDDI.d520.s11.e4" interaction="false"/><pair id="DrugDDI.d520.s11.p16" e1="DrugDDI.d520.s11.e3" e2="DrugDDI.d520.s11.e5" interaction="true"/><pair id="DrugDDI.d520.s11.p17" e1="DrugDDI.d520.s11.e3" e2="DrugDDI.d520.s11.e6" interaction="false"/><pair id="DrugDDI.d520.s11.p18" e1="DrugDDI.d520.s11.e4" e2="DrugDDI.d520.s11.e5" interaction="true"/><pair id="DrugDDI.d520.s11.p19" e1="DrugDDI.d520.s11.e4" e2="DrugDDI.d520.s11.e6" interaction="false"/><pair id="DrugDDI.d520.s11.p20" e1="DrugDDI.d520.s11.e5" e2="DrugDDI.d520.s11.e6" interaction="false"/></sentence><sentence id="DrugDDI.d520.s12" origId="s12" text="Therefore, patients concurrently taking antiseizure medication and Mefloquine should have the blood level of their antiseizure medication monitored and the dosage adjusted appropriately."><entity id="DrugDDI.d520.s12.e0" origId="s12.p162" charOffset="40-63" type="drug" text="antiseizure medication"/><entity id="DrugDDI.d520.s12.e1" origId="s12.p164" charOffset="67-77" type="drug" text="Mefloquine"/><entity id="DrugDDI.d520.s12.e2" origId="s12.p168" charOffset="115-138" type="drug" text="antiseizure medication"/><pair id="DrugDDI.d520.s12.p0" e1="DrugDDI.d520.s12.e0" e2="DrugDDI.d520.s12.e1" interaction="true"/><pair id="DrugDDI.d520.s12.p1" e1="DrugDDI.d520.s12.e0" e2="DrugDDI.d520.s12.e2" interaction="false"/><pair id="DrugDDI.d520.s12.p2" e1="DrugDDI.d520.s12.e1" e2="DrugDDI.d520.s12.e2" interaction="false"/></sentence><sentence id="DrugDDI.d520.s13" origId="s13" text="When Mefloquine is taken concurrently with oral live typhoid vaccines, attenuation of immunization cannot be excluded."><entity id="DrugDDI.d520.s13.e0" origId="s13.p175" charOffset="5-15" type="drug" text="Mefloquine"/><entity id="DrugDDI.d520.s13.e1" origId="s13.p179" charOffset="43-69" type="drug" text="oral live typhoid vaccines"/><pair id="DrugDDI.d520.s13.p0" e1="DrugDDI.d520.s13.e0" e2="DrugDDI.d520.s13.e1" interaction="true"/></sentence><sentence id="DrugDDI.d520.s14" origId="s14" text="Vaccinations with attenuated live bacteria should therefore be completed at least 3 days before the first dose of Mefloquine."><entity id="DrugDDI.d520.s14.e0" origId="s14.p193" charOffset="114-124" type="drug" text="Mefloquine"/></sentence><sentence id="DrugDDI.d520.s15" origId="s15" text="No other drug interactions are known."/><sentence id="DrugDDI.d520.s16" origId="s16" text="Nevertheless, the effects of Mefloquine on travelers receiving comedication, particularly diabetics or patients using anticoagulants, should be checked before departure."><entity id="DrugDDI.d520.s16.e0" origId="s16.p199" charOffset="29-39" type="drug" text="Mefloquine"/><entity id="DrugDDI.d520.s16.e1" origId="s16.p207" charOffset="118-132" type="drug" text="anticoagulants"/><pair id="DrugDDI.d520.s16.p0" e1="DrugDDI.d520.s16.e0" e2="DrugDDI.d520.s16.e1" interaction="true"/></sentence><sentence id="DrugDDI.d520.s17" origId="s17" text="In clinical trials, the concomitant administration of sulfadoxine and pyrimethamine did not alter the adverse reaction profile."><entity id="DrugDDI.d520.s17.e0" origId="s17.p214" charOffset="54-65" type="drug" text="sulfadoxine"/><entity id="DrugDDI.d520.s17.e1" origId="s17.p216" charOffset="70-83" type="drug" text="pyrimethamine"/><pair id="DrugDDI.d520.s17.p0" e1="DrugDDI.d520.s17.e0" e2="DrugDDI.d520.s17.e1" interaction="false"/></sentence></document>